Previous 10 | Next 10 |
home / stock / cl / cl articles
With U.S. stock futures trading lower this morning on Friday, some of the stocks that may grab investor focus today are as follows: Wall Street exp...
Ohio medical cannabis sales hit a new record with $484.4 million worth of products sold in 2023, according to the Ohio Department of Commerce. A re...
The earnings season is gaining momentum as the tech reporting season kicks off this week. With the S&P 500 Index reaching a new high ...
Looking into the current session, Colgate-Palmolive Inc. (NYSE:CL) shares are trading at $78.20, after a 0.37% spike. Moreover, over the past month...
New York Governor Kathy Hochul has revealed plans for the launch of a dozen additional dispensaries selling recreational cannabis, spanning from Br...
The Cannabist Company Holdings Inc. (NEO: CBST) (OTCQX: CBSTF) (FSE: 3LP), formerly Columbia Care, was approved Friday by the New York Office of Ca...
In groundbreaking research published this month in the Journal of Dental Research, scientists from Rutgers University and the University of Texas r...
The third-quarter earnings season has largely been mixed so far, reflecting the impact of the economic uncertainties on profit growth. That said, d...
It’s a mixed Friday on Wall Street, with tech investors cheering stellar earnings from Amazon.com, Inc. (NASDAQ:AMZN) and an in-line personal...
News, Short Squeeze, Breakout and More Instantly...
Colgate-Palmolive Company Company Name:
CL Stock Symbol:
NYSE Market:
Colgate-Palmolive Company Website:
Shares of Colgate-Palmolive Company (NYSE: CL) traded at a new 52-week high today and are currently trading at $100.31. So far today, approximately 1.09M shares have been exchanged, as compared to an average 30-day volume of 3.69M shares. Colgate-Palmolive Company, together with its subsidiar...
2024-07-26 15:15:03 ET HSBC analyst issues HOLD recommendation for CL on July 26, 2024 01:54PM ET. CL was trading at $99.51 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst recommendations are : 12 - Buy, 5 - Hold recommendatio...
Bogota Financial Corp. (BSBK) is expected to report for Q2 2024 Capital Product Partners L.P. (CPLP) is expected to report $0.17 for Q2 2024 Colgate-Palmolive Company (CL) is expected to report $0.87 for Q2 2024 ARCA biopharma Inc. (ABIO) is expected to report for Q2 2024 Barnes G...